NBIX
Neurocrine Biosciences, Inc. · Healthcare
Director Stephen A Sherwin sold $3.6M of Neurocrine Biosciences, Inc.
Sold$3,565,728
$118.86Price
30,000Shares
−54%Stake
What NBIX did after the filing
- The stock from Thu, Jan 5 close, $122.95
- −15.8%
- S&P 500, same days
- +7.3%
Measured over 30 trading days, to the Feb 17 close.
Traded Tue, Jan 3. Filed Thu, Jan 5, 1:21 PM ET, during the session. Returns use the Jan 5 close and the Feb 17 close. Not investment advice.